SCPHARMACEUTICALS INC. Accounts Receivable
SCPHARMACEUTICALS INC. had Accounts Receivable of $19.41 million as of 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2025-08-07
- 2025-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $19.41M.
- 2025-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $13.85M.
- 2024-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $11.72M.
- 2024-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $9.22M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2025-06-30 | $19.41M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $13.85M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $11.72M 10-Q · filed 2025-08-07 |
| 2024-09-30 | $9.22M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $6.12M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $5.77M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $4.49M 10-K · filed 2025-03-19 |
| 2023-09-30 | $4.17M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $1.61M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $3.00M 10-Q · filed 2023-05-10 |